Breast CT technology developer Izotropic has released a commercial prototype of its breast CT device, IzoView.
The prototype will be used in clinical studies to support the company's application for U.S. market authorization, it said. The device is self-shielding, which allows it to contain radiation emitted during the exam inside itself so that only the patient's breast is exposed to radiation.
Izotropic has unveiled a commercial prototype of its IzoView device.Izotropic has begun filing patents on particular features of IzoView, which it will co-own with the University of California, from which it has received exclusive, global licensing rights for the IzoView technology, the company said.
